Four-dimensional ultrasound imaging of complex biological systems such as the brain is technically challenging because of the spatiotemporal sampling requirements. We present computational ultrasound imaging (cUSi), an imaging method that uses complex ultrasound fields that can be generated with simple hardware and a physical wave prediction model to alleviate the sampling constraints. cUSi allows for high-resolution four-dimensional imaging of brain hemodynamics in awake and anesthetized mice.
3 October 2023 in IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
Volumetric 3D Doppler ultrasound imaging can be used to investigate large scale blood dynamics outside of the limited view that conventional 2D power Doppler images (PDIs) provide. To create 3D PDIs, 2D-matrix array transducers can be used to insonify a large volume for every transmission, however these matrices suffer from low sensitivity, high complexity, and high cost. More typically, a 1D-array transducer is used to scan a series of stationary 2D PDIs, after which a 3D volume is created by concatenating the 2D PDIs in post-processing, which results in long scan times due to the repeated measurements. Our objective was to achieve volumetric 3D Doppler ultrasound imaging with a high Doppler sensitivity, similar to that of a typical stationary recording using a 1D-array transducer, while being more affordable than using 2D-matrix arrays. We achieved this by mounting a 1D-array transducer to a high precision motorized linear stage and continuously translating over the mouse brain in a sweeping manner. For Part I of this paper we focused on creating the best vascular images by investigating how to best combine filtered beamformed ultrasound frames, that were not acquired at the same spatial locations, into PDIs. Part II focuses on the implications of sampling transient brain hemodynamics through functional ultrasound while continuously translating over the mouse brain. In Part I we show how the speed at which we sweep our 1D-array transducer effects the Doppler spectrum in a flow phantom. In-vivo recordings were performed on the mouse brain while varying the sweeping speed, showing how higher sweeping speeds negatively effect the PDI quality. A weighting vector is found to combine frames while continuously moving over the mouse brain, allowing us to create swept PDIs of similar sensitivity when compared to those obtained using a stationary 1D-array while allowing a significantly higher 3D Doppler volume rate and maintaining the benefits of having a low computational and monetary cost. We show that a vascular sub-volume of 6 mm can be scanned in 2.5 seconds, with a PDI reconstructed every 200 μm, outperforming classical staged recording methods.
Individuals with Neurofibromatosis type 1 (NF1) experience a high degree of motor problems. The cerebellum plays a pivotal role in motor functioning and the NF1 gene is highly expressed in cerebellar Purkinje cells. However, it is not well understood to what extent NF1 affects cerebellar functioning and how this relates to NF1 motor functioning. Therefore, we subjected global Nf1+/− mice to a cerebellum-dependent associative learning task, called Pavlovian eyeblink conditioning. Additionally, we assessed general motor function and muscle strength in Nf1+/− mice. To our surprise, we found that Nf1+/− mice showed a moderately increased learning rate of conditioned eyeblink responses, as well as improved accuracy in the adaptive timing of the eyeblink responses. Locomotion, balance, general motor function, and muscle strength were not affected in Nf1+/− mice. Together, our results support the view that cerebellar function in Nf1+/− mice is unimpaired.
Background: Glioblastoma is an aggressive and incurable type of brain cancer. Little progress has been made in the development of effective new therapies in the past decades. The blood–brain barrier (BBB) and drug efflux pumps, which together hamper drug delivery to these tumors, play a pivotal role in the gap between promising preclinical findings and failure in clinical trials. Therefore, selecting drugs that can reach the tumor region in pharmacologically effective concentrations is of major importance. Methods: In the current study, we utilized a drug selection platform to identify candidate drugs by combining in vitro oncological drug screening data and pharmacokinetic (PK) profiles for central nervous system (CNS) penetration using the multiparameter optimization (MPO) score. Furthermore, we developed intracranial patient-derived xenograft (PDX) models that recapitulated the in situ characteristics of glioblastoma and characterized them in terms of vascular integrity, BBB permeability and expression of ATP-binding cassette (ABC) transporters. Omacetaxine mepesuccinate (OMA) was selected as a proof-of-concept drug candidate to validate our drug selection pipeline. Results: We assessed OMA’s PK profile in three different orthotopic mouse PDX models and found that OMA reaches the brain tumor tissue at concentrations ranging from 2- to 11-fold higher than in vitro IC50 values on patient-derived glioblastoma cell cultures. Conclusions: This study demonstrates that OMA, a drug selected for its in vitro anti-glioma activity and CNS- MPO score, achieves brain tumor tissue concentrations exceeding its in vitro IC50 values in patient-derived glioblastoma cell cultures, as shown in three orthotopic mouse PDX models. We emphasize the importance of such approaches at the preclinical level, highlighting both their significance and limitations in identifying compounds with potential clinical implementation in glioblastoma.
8 November 2023 in IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
Functional ultrasound (fUS) using a 1D-array transducer normally is insufficient to capture volumetric functional activity due to being restricted to imaging a single brain slice at a time. Typically, for volumetric fUS, functional recordings are repeated many times as the transducer is moved to a new location after each recording, resulting in a non-unique average mapping of the brain response and long scan times. Our objective was to perform volumetric 3D fUS in an efficient and cost-effective manner. This was achieved by mounting a 1D-array transducer to a high precision motorized linear stage and continuously translating over the mouse brain in a sweeping manner. We show how the speed at which the 1D-array is translated over the brain effects the sampling of the hemodynamic response during visual stimulation as well as the quality of the resulting Power Doppler Image (PDI). Functional activation maps were compared between stationary recordings, where only one functional slice is obtained for every recording, and our swept-3D method, where volumetric fUS was achieved in a single functional recording. The results show that the activation maps obtained with our method closely resemble those obtained during a stationary recording for that same location, while our method is not restricted to functional imaging of a single slice. Lastly, a mouse brain sub-volume of ~6 mm is scanned at a volume rate of 1.5 seconds per volume, with a functional PDI reconstructed every 200 μm, highlighting swept-3D’s potential for volumetric fUS. Our method provides an affordable alternative to volumetric fUS using 2D-matrix transducers, with a high SNR due to using a fully sampled 1D-array transducer, and without the need to repeat functional measurements for every 2D slice, as is most often the case when using a 1D-array. This places our swept-3D method as a potentially valuable addition to conventional 2D fUS, especially when investigating whole-brain functional connectivity, or when shorter recording durations are desired.
Williams syndrome is a developmental disorder caused by a microdeletion entailing the loss of a single copy of 25–27 genes on chromosome 7q11.23. Patients suffer from cardiovascular and neuropsychological symptoms. Structural abnormalities of the cardiovascular system in Williams syndrome have been attributed to the hemizygous loss of the elastin (ELN) gene. In contrast, the neuropsychological consequences of Williams syndrome, including sensorimotor deficits, hypersociability, and cognitive impairments, have been mainly attributed to altered expression of transcription factors, like LIMK1, GTF2I, and GTF2IRD1, while the potential impact of altered cerebrovascular function has been largely overlooked. To study the relationship between Williams syndrome mutations and vascularization of both the heart and brain, we generated a mouse model carrying a relatively long microdeletion Del(5Ncf1-Fkbp6). Heterozygous Del(5Ncf1-Fkbp6) mice had elongated and tortuous aortas but, unlike Eln haploinsufficient mice, showed no signs of structural cardiac hypertrophy. Remarkably, we also observed structural abnormalities in coronary and brain vessels, including disorganized extracellular matrices. Importantly, the mutant mice faithfully replicated both cardiovascular and neuropsychological symptoms observed in patients. The phenotype was even more comprehensive than in former models, with structure–function correlations evident in aberrant auditory and motor behaviors resembling those in patients with Williams syndrome. Together, our findings suggest that not only cardiovascular but also neuropsychological symptoms in Williams syndrome may be driven in part by vascular abnormalities affecting both heart and brain.